Sensus Healthcare to Showcase its Full Line of Cutting-Edge Superficial Radiotherapy Devices for the Treatment of Non-melanoma Skin Cancer at ASTRO 2023 in San Diego
BOCA RATON, Fla, Sept. 26, 2023 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces its...
Sensus Healthcare Announces New $3 Million Share Repurchase Program
BOCA RATON, Fla., Aug. 08, 2023 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that its...
Sensus Healthcare Announces New $3 Million Share Repurchase Program
BOCA RATON, Fla., Aug. 08, 2023 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that its...
Sensus Healthcare Reports Second Quarter 2023 Financial Results
Revenues increased 33% and system shipments increased 30%, both compared with the first quarter of 2023Achieved a milestone with the installation of 700 systems for a total of 708 Expects to ship at least 60 SRT units during 2023 and to return to profitability in the...
Sensus Healthcare to Host Second Quarter 2023 Financial Results and Business Update Conference Call on Thursday, August 3, 2023
BOCA RATON, Fla., July 26, 2023 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on...